Interferon-gamma (INF-γ), IL4 expression levels and Leishmania DNA load as prognostic markers for monitoring response to treatment of leishmaniotic dogs with miltefosine and allopurinol

Cytokine

Volumn 44, Issue 2, 2008, Pages 288-292

  Manna, Laura ^a   Reale, Stefano ^b   Picillo, Esther ^a   Vitale, Fabrizio ^b   Gravino, Angelo Elio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLA SICILIA A MIRRI   (Italy)

Author keywords

Cytokine; Dog; Leishmania infantum; Real time PCR

Indexed keywords

ALBUMIN; ALLOPURINOL; BIOLOGICAL MARKER; CREATININE; GAMMA INTERFERON; GLOBULIN; INTERLEUKIN 4; MILTEFOSINE; UREA;

ALBUMIN BLOOD LEVEL; ALOPECIA; ANIMAL TISSUE; ARTICLE; BABESIOSIS; BLOOD SAMPLING; BLOODY DIARRHEA; CREATININE BLOOD LEVEL; DERMATITIS; DIFFERENTIAL DIAGNOSIS; DNA EXTRACTION; DOG; EHRLICHIOSIS; EPISTAXIS; EYE INJURY; IMMUNE RESPONSE; LEISHMANIA; LEISHMANIA INFANTUM; LEISHMANIASIS; LEPTOSPIROSIS; LYMPH NODE; LYMPHADENOPATHY; NEEDLE BIOPSY; NONHUMAN; PARASITE EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RELAPSE; SKIN ULCER; TREATMENT RESPONSE; UREA BLOOD LEVEL; WEIGHT REDUCTION;

ALLOPURINOL; ANIMALS; ANTIPROTOZOAL AGENTS; BIOLOGICAL MARKERS; DNA, PROTOZOAN; DOG DISEASES; DOGS; INTERFERON-GAMMA; INTERLEUKIN-4; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; PHOSPHORYLCHOLINE;

ANIMALIA; CANIS FAMILIARIS; LEISHMANIA INFANTUM;

EID: 56049096697     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.08.017     Document Type: Article

References (50)

1. Herwaldt B.L. Leishmaniasis. Lancet 354 (1999) 1191-1199
2. World Health Organization, 2001. WHO information by topics or disease: http://www.who.int/emc/diseases/leish/index.html.
3. Desjeux P., and Alvar J. Leishmania/HIV co-infections: epidemiology in Europe. Ann Trop Med Parasitol 97 (2003) 3-15
4. Ashford R.W. The leishmaniases as emerging and reemerging zoonoses. Int J Parasitol 30 (2000) 1269-1281
5. Courtenay O., Quinnell R.J., Garcez L.M., and Dye C. Low infectiousness of a wildlife host of Leishmania infantum: the crab-eating fox is not important for transmission. Parasitology 125 (2002) 407-414
6. Chamizo C., Moreno J., and Alvar J. Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis. Vet Immunol Immunopathol 103 (2005) 67-75
7. Dye C., Killick-Kendrick R., Vitutia M.M., Walton R., Killick-Kendrick M., Harith A.E., et al. Epidemiology of canine leishmaniasis: prevalence, incidence and basic reproduction number calculated from a cross-sectional serological survey on the island of Gozo, Malta. Parasitology 105 (1992) 35-41
8. Solano-Gallego L., Morell P., Arboix M., Alberola J., and Ferrer L. Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology. J Clin Microb 39 (2001) 560-563
9. Alvar J., Caňavate C., Molina R., Moreno J., and Nieto J. Canine leishmaniasis. Adv Parasitol 57 (2004) 1-88
10. Moreno J., and Alvar J. Canine leishmaniasis: epidemiological risk and the experimental model. Trends Parasitol 18 (2002) 399-405
11. Gradoni L., Maroli M., Gramiccia M., and Mancianti F. Leishmania infantum infection rates in Phlebotomus perniciosus fed on naturally infected dogs under antimonial treatment. Med Vet Entomol 1 (1987) 339-342
12. Molina R., Amela C., Nieto J., San-Andres M., Gonzalez F., Castillo J.A., et al. Infectivity of dogs naturally infected with Leishmania infantum to colonized Phlebotomus perniciosus. Trans R Soc Trop Med Hyg 88 (1994) 491-493
13. Courtenay O., Quinnell R.J., Garcez L.M., Shaw J.J., and Dye C. Infectiousness in a cohort of Brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission. J Infect Dis 186 (2002) 1314-1320
14. Pinelli E., van der Kaaij S.Y., Slappendel R., Fragio C., Ruitenberg E.J., Bernadina W., et al. Detection of canine cytokine gene expression by reverse transcription-polymerase chain reaction. Vet Immunol Immunopathol 69 (1999) 121-126
15. Gradoni L., and Ascenzi P. Nitric oxide and anti-protozoan chemotherapy. Parassitologia 46 (2004) 101-103
16. Sundar S., Reed S.G., Sharma S., Mehrotra A., and Murray H.W. Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis. Am J Trop Med Hyg 56 (1997) 522-525
17. Babaloo Z., Kaye P.M., and Eslami M.B. IL-13 in Iranian patients with visceral leishmaniasis: relationship to other Th2 and to Th1 cytokines. Trans R Soc Trop Med Hyg 95 (2001) 85-88
18. Thakur C.P., Mitra D.K., and Narayan S. Skewing of cytokine profiles towards T helper cell type 2 response in visceral leishmaniasis patients unresponsive to sodium antimony gluconate. Trans R Soc Trop Med Hyg 97 (2003) 409-412
19. Nylén S., and Sacks D. Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol 28 (2007) 378-384 Review
20. Bretagne S., Durand R., Olivi M., Garin J.F., Sulahian A., Rivollet D., et al. Real-time PCR as a new tool for quantifying Leishmania infantum in liver in infected mice. Clin Diagn Lab Immunol 8 (2001) 828-831
21. Nicolas L., Prina E., Lang T., and Milon G. Real-time PCR for detection and quantitation of Leishmania in mouse tissues. J Clin Microbiol 40 (2002) 1666-1669
22. Schulz A., Mellenthin K., Schonian G., Fleischer B., and Drosten C. Detection, differentiation and quantitation of pathogenic Leishmania organisms by fluorescence resonance energy transfer-based real-time PCR assay. J Clin Microbiol 41 (2003) 1529-1535
23. Mary C., Faraut F., Lascombe L., and Dumon H. Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity. J Clin Microbiol 42 (2004) 5249-5255
24. Rolão N., Cortes S., Rodrigues O.R., and Campino L. Quantification of Leishmania infantum parasites in tissue biopsies by real-time polymerase chain reaction and polymerase chain reaction-enzyme-linked immunosorbent assay. J Parasitol 90 (2004) 1150-1154
25. Van der Meide W.F., Schoone G.J., Faber W.R., Zeegelaar J.E., de Vries H.J., Ozbel Y., et al. Quantitative nucleic acid sequence-based assay as a new molecular tool for detection and quantification of Leishmania parasites in skin biopsy samples. J Clin Microbiol 43 (2005) 5560-5566
26. Francino O., Altet L., Sánchez-Robert E., Rodriguez A., Solano-Gallego L., Alberola J., et al. Advantages of real-time PCR assay for diagnosis and monitoring of canine leishmaniosis. Vet Parasitol 137 (2006) 214-221
27. Manna L., Reale S., Viola E., Vitale F., Manzillo V.F., Michele P.L., et al. Leishmania DNA load and cytokine expression levels in asymptomatic naturally infected dogs. Vet Parasitol 142 (2006) 271-280
28. Croft S.L., Sundar S., and Fairlamb A.H. Drug resistance in leishmaniasis. Clin Microbiol Rev 19 (2006) 111-126 Review
29. Rhalem A., Sahibi H., Lasri S., and Jaffe C.L. Analysis of immune responses in dogs with canine visceral leishmaniasis before, and after, drug treatment. Vet Immunol Immunopathol 71 (1999) 69-76
30. Troya J., Casquero A., Refolo E., Fernández-Guerrero M.L., and Górgolas M. Long term failure of miltefosine in the treatment of refractory visceral leishmaniasis in AIDS patients. Scand J Infect Dis 40 (2008) 78-80
31. Manna L., Gravino A.E., Picillo E., Decaro N., and Buonavoglia C. Leishmania DNA quantification by real-time PCR in naturally infected dogs treated with miltefosine. Ann N Y Acad Sci (2008)
32. Manna L., Vitale F., Reale S., Caracappa S., Pavone L.M., Della Morte R., et al. Comparison of different tissue sampling for PCR-based diagnosis and follow-up of canine visceral leishmaniosis. Vet Parasitol 125 (2004) 251-262
33. SPSS 12.0 User Guide. New York: McGraw-Hill; 2005.
34. Wilson M.E., and Jeronimo S.M.B. Pearson RDx Immunopathogenesis of infection with the visceralizing Leishmania species. Microb Pathog 38 (2005) 147-160
35. Murray H.W., Montelibano C., Peterson R., and Sypek J.P. Interleukin 12 regulates the response to chemotherapy in experimental visceral leishmaniasis. J Infect Dis 182 (2000) 1497-1502
36. Kaye P.M., Svensson M., Ato M., Maroof A., Polley R., Stager S., et al. The immunopathology of experimental visceral leishmaniasis. Immunol Rev 201 (2004) 239-253
37. Murray H.W., Miralles G.D., Stoeckle M.Y., and McDermott D.F. Role and effect of interleukin-2 in experimental visceral leishmaniasis. J Immunol 151 (1993) 929-934
38. Murray H.W., Cervia J., Hariprashad J., Taylor A.P., Stoeckle M.Y., and Hockman H. Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis. J Clin Investig 95 (1995) 1183-1189
39. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13 (1995) 251-276
40. Takeda Tsutsui K.H., Yoshimoto H.T., Adachi O., Yoshida N., Kishimoto T., Okamura H., et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8 (1998) 383-390
41. Muller U., Kohler G., Mossmann H., Schaub G.A., Alber G., Di Santo J.P., et al. IL-12-independent IFN-γ production by T cells in experimental Chagas' disease is mediated by IL-18. J Immunol 167 (2001) 3346-3353
42. Herring A.C., Lee J., McDonald R.A., Toews G.B., and Huffnagle G.B. Induction of interleukin 12 and gamma interferon requires tumor necrosis factor alpha for protective Th1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection. Infect Immun 70 (2002) 2959-2964
43. Villegas E.N., Lieberman L.A., Carding S.R., and Hunter C.A. Susceptibility of interleukin-2 deficient mice to Toxoplasma gondii is associated with a defect in the production of gamma interferon. Infect Immun 70 (2002) 4757-4761
44. Strengell M., Matikainen S., Siren J., Lehtonen A., Foster D., Julkunen I., et al. IL-21 in synergy with IL-15 or IL-18 enhances IFN-γ production in human NK and T cells. J Immunol 170 (2003) 5465-5469
45. Ing R., Gros P., and Stevenson M.M. Interleukin-15 enhances innate and adaptive immune responses to blood-stage malaria infection in mice. Infect Immun 73 (2005) 3172-3177
46. Khader S.A., Pearl J.E., Sakamtot K., Gilmartin L., Bell G.K., Jelley-Gibbs D.M., et al. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen specific IFN-γ responses if IL-12p70 is available. J Immunol 175 (2005) 788-795
47. Stager S., Alexander J., Carter K.C., Brombacher F., and Kaye P.M. Both interleukin-4 (IL-4) and IL-4 receptor α signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity. Infect Immun 71 (2003) 4804-4807
48. Scott P., Artis D., Uzonna J., and Zaph C. The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development. Immunol Rev 201 (2004) 318-338
49. Afonso L.C., Scharton T.M., Vieira L.Q., Wysocka M., Trinchieri G., and Scott P. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263 (1994) 235-237
50. Sjölander A., Baldwin T.M., Curtis J.M., Bengtsson K.L., and Handman E.V. Accination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection. Vaccine 16 (1998) 2077-2084